|
Match
|
Document |
Document Title |
|
|
US20090285905 |
SYSTEMS AND PROCESSES FOR SPRAY DRYING HYDROPHOBIC DRUGS WITH HYDROPHILIC EXCIPIENTS
Methods for preparing dry powders having hydrophobic and hydrophilic components comprise combining solutions of the components and spray drying them simultaneously in a spray dryer. The hydrophilic...
|
|
|
US20090285903 |
METHODS FOR DENDRITIC CELL THERAPY USING PHARMACOLOGICALLY ACTIVE MICROCARRIERS
Monocytes and dendritic cells are grafted to the surface of microparticles for use as a therapeutic device for stimulating a post-injection immune response in vivo. Various embodiments include an...
|
|
|
US20090285902 |
DIETARY SUPPLEMENT COMPOSITION FOR BLOOD LIPID HEALTH
A human or animal dietary supplement composition comprising one or more long chain (C24-C36) primary alcohols (policosanols) dispersed in food-grade oils or fats where the policosanol particle size...
|
|
|
US20090285901 |
Polyamino acid for use as adjuvant
Use of a polyamino acid as an adjuvant; an application of a polyamino acid as an adjuvant in the production of a vaccine; a vaccine comprising a polyamino acid as an adjuvant; a biodegradable...
|
|
|
US20090285900 |
COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A BETA-AGONIST BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulfate, or a salt thereof, and a second active agent...
|
|
|
US20090285899 |
COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH A METHYLXANTHINE DERIVATIVE FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulfate, or a salt thereof, and a second active agent...
|
|
|
US20090285898 |
COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE-SULFATE WITH AN ANTICHOLINERGIC BRONCHODILATOR FOR TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
A pharmaceutical or veterinary composition, comprises a first active agent selected from a dehydroepiandrosterone and/or dehydroepiandrosterone-sulfate, or a salt thereof, and a second active agent...
|
|
|
US20090280185 |
Particulate wood preservative and method for producing the same
A wood preservative includes injectable particles comprising one or more sparingly soluble copper salts. The copper-based particles are sufficiently insoluble so as to not be easily removed by...
|
|
|
US20090280184 |
PHARMACEUTICAL COMPOSITION, METHOD OF PREPARATION AND METHODS OF TREATING ACHES/PAINS
Provided are methods and compositions useful for treating/aches and/or pains. The compositions comprise an herbal therapeutic agent and an analgesic agent, wherein the composition is effective when...
|
|
|
US20090280181 |
DELIVERY OF NUCLEIC ACID COMPLEXES FROM PARTICLES
Embodiments of the invention include particles with nucleic acid complexes, medical devices including the same and related methods. In an embodiment, the invention can include a method of making a...
|
|
|
US20090280176 |
CONTROLLED RELEASE FORMULATIONS OF ALPRAZOLAM
A controlled release formulation of alprazolam for once a day administration to a mammalian subject, which formulation releases alprazolam along a pre-determined release profile, is provided.
|
|
|
US20090280160 |
PHENYLEPHRINE PHARMACEUTICAL FORMULATIONS AND COMPOSITIONS FOR TRANSMUCOSAL ABSORPTION
Pharmaceutical compositions comprising phenylephrine or a pharmaceutically acceptable salt thereof and methods for administering the pharmaceutical compositions wherein the composition is...
|
|
|
US20090280148 |
CASEIN NANOPARTICLE
An object of the present invention to provide: a nanoparticle, which can be produced without the use of surfactants and synthetic polymers, which has a controllable size and is stable in the acidic...
|
|
|
US20090274764 |
Hollow Foam Beads for Treatment of Glioblastoma
Compositions and methods for the treatment of tumors are disclosed. Specifically, the present invention provides hollow foam beads having a chemotherapeutic agent incorporated therein. A method of...
|
|
|
US20090274763 |
IMMUNOADJUVANT
An immunoadjuvant comprising one kind or two or more kinds of immunostimulating substances carried separately by two or more kinds of different microparticle immunostimulating substance carriers,...
|
|
|
US20090274734 |
METHOD FOR OBTAINING HOLLOW PARTICLES
Described is a method for obtaining hollow particles, having a particle wall and a particle lumen, the particle having dimensions of between 1 nm and 100 μm, from a mixture comprising a liquid...
|
|
|
US20090269410 |
Inhibition of Neovascularization by Cerium Oxide Nanoparticles
The present invention provides methods for reducing, reversing or inhibiting neovascularization in a tissue of a mammalian subject having a pathological condition involving neovascularization by...
|
|
|
US20090269409 |
PHARMACEUTICAL COMPOSITIONS COMPRISING ESZOPICLONE
Pharmaceutical compositions comprising eszopiclone, including its pharmaceutically acceptable salts, hydrates, clathrates, solvates, polymorphs, and mixtures thereof. The invention also relates to...
|
|
|
US20090269408 |
Aqueous formulations of imidoalkanepercarboxylic acids
Liquid formulations of imidoalkanepercarboxylic acids, in the form of aqueous dispersions comprising, in percentages by weight relative to the total weight of the composition: A) from ≧7% to 40%...
|
|
|
US20090269400 |
Nanoparticulate and Controlled Release Compositions Comprising a Cephalosporin
The present invention is directed to compositions comprising a nanoparticulate antibiotic having improved bioavailability. Preferably, the antibiotic comprises nanoparticulate cephalosporin...
|
|
|
US20090269397 |
TARGETED AND HIGH DENSITY DRUG LOADED POLYMERIC MATERIALS
Polymeric delivery devices have been developed which combine high loading/high density of molecules to be delivered with the option of targeting. As used herein, “high density” refers to...
|
|
|
US20090269394 |
METHODS AND COMPOSITIONS FOR TREATING ONCHOMYCOSIS
The present invention relates to methods for treating and completely curing fungal, yeast and/or mold infections in human subjects comprising topically administering to a human subject in need...
|
|
|
US20090269279 |
Toxicology and Cellular Effect of Manufactured Nanomaterials
The increasing use of nanotechnology in consumer products and medical applications underlies the importance of understanding its potential toxic effects to people and the environment. Herein are...
|
|
|
US20090263488 |
PRESSURISED METERED DOSE INHALERS CONTAINING SOLUTIONS OF BETA-2 AGONISTS
The present invention relates to a pharmaceutical formulation for use in the administration of 2(1H)-quinolinone derivatives long-acting β 2 -agonists by inhalation. In particular this invention...
|
|
|
US20090263487 |
Bubble drink provided by bubbling engineering progress
A bubble drink as a health food, which is produced by imparting a catalytic function for gas escaping to an adsorptive fine food powder to allow the fine food powder to be dispersed in a colloidal...
|
|
|
US20090263486 |
NANOPARTICLE-STABILIZED CAPSULE FORMULATION FOR TREATMENT OF INFLAMMATION
A formulation for the delivery of an anti-inflammatory agent to a subject is described. In one particular application of the invention, the formulation comprises oil-based or aqueous droplets...
|
|
|
US20090263485 |
Targeted hollow gold nanostructures and methods of use
Provided are novel nanostructures comprising hollow nanospheres and nanotubes for use as chemical sensors and molecular specific photothermal coupling agents. The nanostructures can be used in...
|
|
|
US20090263475 |
DEXLANSOPRAZOLE COMPOSITIONS
Premixes of dexlansoprazole with pharmaceutical excipients, processes for preparing premixes, pharmaceutical formulations containing the premixes, and their use in treatment of erosive esophagitis...
|
|
|
US20090263453 |
Methods and Compositions for Treating Pain Comprising a Statin
Methods and compositions are provided for reducing, treating or preventing pain and/or inflammation in a patient in need of such treatment, the methods and compositions comprising administering a...
|
|
|
US20090263434 |
POWDER COMPOSED OF INORGANIC COMPOUND-LOADED POLYAMIDE POROUS PARTICLE
Powder composed of fine inorganic compound particles-deposited porous polyamide particles in which the inorganic compound particles are deposited on surfaces and in pores of the porous polyamide...
|
|
|
US20090263327 |
MINIMALLY INVASIVE PHYSIOLOGICAL FUNCTION MONITORING AGENTS
Highly hydrophilic indole and benzoindole derivatives that absorb and fluoresce in the visible region of light are disclosed. These compounds are useful for physiological and organ function...
|
|
|
US20090259160 |
SYSTEM AND COMPOSITION FOR DENDRITIC CELL THERAPY USING PHARMACOLOGICALLY ACTIVE MICROCARRIERS
Monocytes and dendritic cells are grafted to the surface of microparticles for use as a therapeutic device for stimulating a post-injection immune response in vivo. Various embodiments include an...
|
|
|
US20090258088 |
USE OF MATERIALS AND EXTERNAL STIMULI FOR SYNOVECTOMY
This invention has as one of its aspects a method to provide a safe an effective treatment for synovectomy. The method involves the administration a material to the affected joint, allowing the...
|
|
|
US20090258075 |
Respiratory Drug Condensation Aerosols and Methods of Making and Using Them
Described herein are respiratory drug condensation aerosols and methods of making and using them. Kits for delivering condensation aerosols are also described. The respiratory drug aerosols...
|
|
|
US20090258073 |
MAGNETIC CARRIER AND MEDICAL PREPARATION FOR CONTROLLABLE DELIVERY AND RELEASE OF ACTIVE SUBSTANCES, METHODS OF THEIR PRODUCTION AND METHODS OF TREATMENT USING THEREOF
The present invention relates to magnetic carriers and medical preparations for controllable delivery and release of active substances. The carrier for active substances comprises material A, which...
|
|
|
US20090258072 |
LARGE ULTRAVIOLET ATTENUATING PIGMENTS
Large particle sunscreen powders useful as ingredients in cosmetic compositions and in dispersions for incorporation into cosmetic compositions comprise a UV shielding agent in a matrix material....
|
|
|
US20090258071 |
COMPOSITIONS AND METHODS FOR PH TARGETED DRUG DELIVERY
The invention provides compositions and methods for the targeted, in particular, pH targeted, delivery of pharmaceutically active agents in mammals. The compositions comprise pH sensitive diblock...
|
|
|
US20090258070 |
Topical LFA-1 antagonists for use in localized treatment of immune related disorders
This invention provides specifically formulated LFA-1 antagonists or pharmaceutically acceptable salts thereof that are suitable for topical delivery. In particular, the LFA-1 antagonists are...
|
|
|
US20090258069 |
Delivery of LFA-1 antagonists to the gastrointestinal system
The present invention provides compositions and methods for treating disorders and diseases by delivery of LFA-1 antagonists to the gastrointestinal system. Methods include delivery of LFA-1...
|
|
|
US20090258068 |
Titanium Oxide-Zinc Oxide Aggregate Powder And Production Method Thereof
The present invention provides a powder that can display excellent protection ability in both UV-A and UV-B regions. The titanium oxide-zinc oxide aggregate powder comprises an aggregate formed by...
|
|
|
US20090252807 |
Nanoparticulate and Controlled Release Compositions Comprising Prostaglandin Derivatives
The present invention is directed to compositions comprising a nanoparticulate prostaglandin derivative, preferably limaprost or a salt or derivative thereof, having improved bioavailability. The...
|
|
|
US20090252806 |
NANOPARTICULATE TACROLIMUS FORMULATIONS
The present invention is directed to nanoparticulate tacrolimus compositions. The composition comprising tacrolimus particles having an effective average particle size of less than about 2000 nm...
|
|
|
US20090252804 |
MEDICAL DEVICES WITH AN ANTIBACTERIAL POLYURETHANEUREA COATING
The present invention relates to a medical device which has at least one coating which is obtained starting from an aqueous dispersion, the aqueous dispersion comprising at least one nonionically...
|
|
|
US20090252803 |
GLYCYRRHETINIC ACID-MEDIATED NANOPARTICLES OF HEPATIC TARGETED DRUG DELIVERY SYSTEM, PROCESS FOR PREPARING THE SAME AND USE THEREOF
Disclosed are a hepatic targeted drug delivery system and a process for preparing the same. Also disclosed is a method for treating liver cancer.
|
|
|
US20090252802 |
Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same
Compositions including therapeutic components and surfactant components which enhance the utility of the therapeutic components and methods of using such compositions are provided.
|
|
|
US20090252801 |
Process for the Preparation of Micronised Sterile Steroids
The present invention relates to a process for the preparation of micronised sterile steroids, comprising sterilisation of the steroids in crystalline form by means of irradiation with gamma or...
|
|
|
US20090252793 |
PHARMACEUTICAL COMPOSITIONS
Oral dosage forms comprising oxcarbazepine which when administered to a patient display no food effect.
|
|
|
US20090246284 |
O-desmethylvenlafaxine Cocrystals
Disclosed herein are co-crystals comprising O-desmethylvenlafaxine and succinic acid, process for the preparation, pharmaceutical compositions, and method of treating thereof.
|
|
|
US20090246283 |
Repeat Sequence Protein Polymer Nanoparticles Optionally Containing Active Agents and Their Preparation
A nanocomposite of a repeat sequence protein polymer, such as a copolymer of silk and elastin, is produced by Supercritical Antisolvent Precipitation with Enhanced Mass Transfer (SAS-EM). The...
|
|
|
US20090246282 |
RECOMBINANT GELATIN PARTICLES FOR CELL ADHESION
The present invention relates to cell carrier particles prepared from recombinantly produced gelatins comprising at least two outer lysine residues which are separated by at least 25 percent of the...
|